Category Archives: News

FDA Approves Genentech’s Tecentriq as a First-Line Monotherapy for Certain People With Metastatic Non-Small Cell Lung Cancer

Print this page South San Francisco, CA — May 18, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq ® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumors have high… Read More: FDA Approves Genentech’s Tecentriq as a First-Line Monotherapy for Certain… »

What $6,553 Buys You in America: A Luxury Watch, a Year at Valdosta State, or a PPO for One – the 2020 Milliman Medical Index

Imagine this: you find yourself with $ 6,553 in your pocket and you can pick one of the following: A new 2020 Breitling Navitimer watch; A year’s in-state tuition at Valdosta State University; or, A PPO for an average individual. Welcome to the annual Milliman Medical Index (MMI), which gauges the yearly price of an… Read More: What $6,553 Buys You in America: A Luxury Watch, a… »

Chocolate Peanut Butter Banana Smoothie

This Chocolate Peanut Butter Banana Smoothie is a delicious and easy way to nourish your body any time of the day! Need I say more? But seriously, this classic combination of flavors is super satisfying, and beyond simple to whip together. Odds are, you have all of these pantry staples on hand already, so you’re… Read More: Chocolate Peanut Butter Banana Smoothie »

Qinlock (Ripretinib) Approved as Fourth-Line Treatment for GIST

MONDAY, May 18, 2020 — The U.S. Food and Drug Administration approved Qinlock (ripretinib) tablets as a fourth-line treatment for adults with advanced gastrointestinal stromal tumors (GISTs), the agency announced Friday. The approval follows four other FDA-approved target therapies for GIST, including imatinib in 2002, sunitinib in 2006, regorafenib in 2013, and avapritinib in January.… Read More: Qinlock (Ripretinib) Approved as Fourth-Line Treatment for GIST »